"Sodium Channel Blockers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity.
Descriptor ID |
D026941
|
MeSH Number(s) |
D27.505.519.562.750 D27.505.954.411.720
|
Concept/Terms |
Sodium Channel Blockers- Sodium Channel Blockers
- Sodium Channel Inhibitors
- Channel Inhibitors, Sodium
- Inhibitors, Sodium Channel
- Channel Blockers, Sodium
|
Below are MeSH descriptors whose meaning is more general than "Sodium Channel Blockers".
Below are MeSH descriptors whose meaning is more specific than "Sodium Channel Blockers".
This graph shows the total number of publications written about "Sodium Channel Blockers" by people in this website by year, and whether "Sodium Channel Blockers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1996 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2005 | 0 | 2 | 2 |
2007 | 0 | 1 | 1 |
2008 | 0 | 2 | 2 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 0 | 2 | 2 |
2013 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sodium Channel Blockers" by people in Profiles.
-
Emergency Department Management of Recent-Onset Atrial Fibrillation. Adv Emerg Nurs J. 2020 Jul/Sep; 42(3):176-185.
-
A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain. Eur J Pharmacol. 2016 Aug 05; 784:1-14.
-
Neural origin of evoked potentials during thalamic deep brain stimulation. J Neurophysiol. 2013 Aug; 110(4):826-43.
-
Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation. 2012 Oct 30; 126(18):2208-19.
-
Use-dependent inhibition of synaptic transmission by the secretion of intravesicularly accumulated antipsychotic drugs. Neuron. 2012 Jun 07; 74(5):830-44.
-
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology. 2011 Jan 25; 76(4):409; author reply 409.
-
Post-treatment with voltage-gated Na(+) channel blocker attenuates kainic acid-induced apoptosis in rat primary hippocampal neurons. Neurochem Res. 2010 Dec; 35(12):2175-83.
-
Arrhythmia exacerbation after sodium channel blockade in myotonic dystrophy type 1. Muscle Nerve. 2009 Nov; 40(5):901-2.
-
Effects of acute and repeated restraint stress on GABA efflux in the rat basolateral and central amygdala. Brain Res. 2009 Feb 23; 1256:61-8.
-
Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2009 Feb; 296(2):L257-66.